Optimizing Collaborative Care of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes: An Example Practice Model at a Health Care Practice in Kentucky, United States Benjamin GatlinJamie MillerSergio Chang Commentary Open access 02 November 2023 Pages: 1 - 11
Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow? Evanthia GouveriDjordje S. PopovicNikolaos Papanas Commentary Open access 11 November 2023 Pages: 13 - 18
The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease Jaap J. van NettenJan ApelqvistNicolaas C. Schaper Commentary Open access 16 November 2023 Pages: 19 - 31
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Anca Pantea StoianIoana-Cristina BicaThe Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO) Review Open access 26 September 2023 Pages: 33 - 60
Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review Jiejin ZhuYing ZhouGang Wang Review Open access 14 November 2023 Pages: 61 - 76
Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies Chloe H. FirmanDuane D. MellorAdrian Brown Review Open access 15 November 2023 Pages: 77 - 97
Is the Current Cut Point for Glycated Haemoglobin (HbA1c) Correct for Diagnosing Diabetes Mellitus in Premenopausal Women? Evidence to Inform Discussion David HollandAnthony A. FryerPensee Wu Original Research Open access 30 September 2023 Pages: 99 - 110
Comparison of Effects of Injectable Semaglutide and Dulaglutide on Oxidative Stress and Glucose Variability in Patients with Type 2 Diabetes Mellitus: A Prospective Preliminary Study Takemasa OmachiMakoto OharaSho-ichi Yamagishi Original Research Open access 25 October 2023 Pages: 111 - 126
Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study Toshiki OtodaAkiko SekineKen-ichi Aihara Original Research Open access 26 October 2023 Pages: 127 - 143
Use of IDegLira to Intensify, Simplify, and Increase Appropriateness of Type 2 Diabetes Therapy: A Real-Life Experience Isabella RomanoRosalia Serra Original Research Open access 26 October 2023 Pages: 145 - 154
Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit Analysis Saud Al SifriRaed AldahashAriel Beresniak Original Research Open access 27 October 2023 Pages: 155 - 164
Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type 1 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation Laura BoswellAntonio J. AmorFelicia A. Hanzu Original Research Open access 02 November 2023 Pages: 165 - 181
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, and Dose-Increasing Study on the Safety, Tolerability and PK/PD of Multiple Doses of HSK7653 by Oral Administration in Patients with Type 2 Diabetes Mellitus in China Nan BaiJin WangYun Cai Original Research Open access 06 November 2023 Pages: 183 - 199
Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes Aiqin HeCaifeng ShiYang Zhou Original Research Open access 14 November 2023 Pages: 201 - 214
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin Aditi JainAbhay VisputeMukesh Jaiswal Original Research Open access 14 November 2023 Pages: 215 - 227
Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims Yixue ShaoLizheng ShiCharles Stoecker Original Research Open access 17 November 2023 Pages: 229 - 243
Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study Yasushi IshigakiTetsuaki HiraseNoriyuki Ishida Brief Report Open access 19 October 2023 Pages: 245 - 256
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production Umberto CapeceChiara PavanelloAlice Ossoli Brief Report Open access 26 October 2023 Pages: 257 - 268
Study Protocol for the Pleiotropic Effects of Sodium–Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes Yumie TakeshitaChiaki NomuraToshinari Takamura Study Protocol Open access 26 October 2023 Pages: 269 - 280
The Hybrid Closed-Loop System Tandem t:slim X2™ with Control-IQ Technology: Expert Recommendations for Better Management and Optimization Ana ChicoJesús Moreno-FernándezEva Solá Practical Approach Open access 20 October 2023 Pages: 281 - 295
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review Anca Pantea StoianIoana-Cristina BicaThe Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO) Correction Open access 15 November 2023 Pages: 297 - 299